- Home
- Personal stories
Personal stories
Johnson & Johnson COVID-19 vaccine named one of Time‘s Best Inventions of 2021.
The vaccine is one of three COVID-19 vaccines sharing joint recognition on the list of groundbreaking innovations this year.
Mobilizing the community to eliminate preventable blindness in children
Recognizing myopia as a public health problem, the Chinese government launched a comprehensive national plan for the prevention and control of myopia. Village doctors like Pan Taoling have a large role to play in achieving the government’s goals.
3 ways Johnson & Johnson is proud to support people with diverse abilities
For International Day of Persons with Disabilities, we’re celebrating how the company has committed to being a safe space for people with diverse physical, neurological and mental health abilities—and sees them as crucial business assets.
Health: the next frontier for impact investing
Health-related impact investments remain limited, even as the field now totals a $715 billion global market. J&J Impact Ventures, an investment fund within the J&J Foundation, is investing in purpose-driven entrepreneurs and their startups in the belief that as their businesses grow, so will their impact.
What you need to know about Johnson & Johnson’s 2021 third-quarter earnings
Check out this infographic breakdown of the company’s third-quarter 2021 performance, with key highlights from its Pharmaceutical, Consumer Health and Medical Devices businesses.
Johnson & Johnson earns a spot on Fortune‘s 2021 Change the World list.
The company is honored to be recognized for its part in helping battle the COVID-19 pandemic.
Curing cancer from within: The promise of cell therapy
Harnessing the immune system to target cancer is the goal of a groundbreaking area of oncology research called cell therapy. And Johnson & Johnson is hard at work in the cutting-edge field, aiming to deliver potential new treatment options to people around the world.
How your own DNA could someday save your vision
Imagine living with a genetic disease that could cause blindness in your 40s—and your doctor tells you there are no treatment options. It’s for patients like these that Johnson & Johnson is harnessing cutting-edge technology in the hope of finding real solutions.
Johnson & Johnson award winner David Julius, Ph.D., receives a 2021 Nobel Prize
The company honored him in 2013 with a Dr. Paul Janssen Award for Biomedical Research; now he’s a Nobel Laureate. Learn about the transformational research that’s led to these well-deserved scientific accolades.